292 related articles for article (PubMed ID: 35430688)
21. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Chiu KWH; Fu J; Vardhanabhuti V
JAMA Netw Open; 2020 Sep; 3(9):e2015927. PubMed ID: 32910196
[TBL] [Abstract][Full Text] [Related]
22. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
23. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
[TBL] [Abstract][Full Text] [Related]
24. Joint use of the radiomics method and frozen sections should be considered in the prediction of the final classification of peripheral lung adenocarcinoma manifesting as ground-glass nodules.
Wang B; Tang Y; Chen Y; Hamal P; Zhu Y; Wang T; Sun Y; Lu Y; Bhuva MS; Meng X; Yang Y; Ai Z; Wu C; Sun X
Lung Cancer; 2020 Jan; 139():103-110. PubMed ID: 31760351
[TBL] [Abstract][Full Text] [Related]
25. Peritumoral radiomics features on preoperative thin-slice CT images can predict the spread through air spaces of lung adenocarcinoma.
Takehana K; Sakamoto R; Fujimoto K; Matsuo Y; Nakajima N; Yoshizawa A; Menju T; Nakamura M; Yamada R; Mizowaki T; Nakamoto Y
Sci Rep; 2022 Jun; 12(1):10323. PubMed ID: 35725754
[TBL] [Abstract][Full Text] [Related]
26. Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.
Dong X; Dan X; Yawen A; Haibo X; Huan L; Mengqi T; Linglong C; Zhao R
Thorac Cancer; 2020 Sep; 11(9):2650-2659. PubMed ID: 32767522
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the combination of intratumoral and peritumoral radiomic signatures for predicting epidermal growth factor receptor mutation in lung adenocarcinoma.
Kawazoe Y; Shiinoki T; Fujimoto K; Yuasa Y; Hirano T; Matsunaga K; Tanaka H
J Appl Clin Med Phys; 2023 Jun; 24(6):e13980. PubMed ID: 37002910
[TBL] [Abstract][Full Text] [Related]
28. A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes.
Shen H; Chen L; Liu K; Zhao K; Li J; Yu L; Ye H; Zhu W
Quant Imaging Med Surg; 2021 Jul; 11(7):2918-2932. PubMed ID: 34249623
[TBL] [Abstract][Full Text] [Related]
29. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
[TBL] [Abstract][Full Text] [Related]
30. The CT delta-radiomics based machine learning approach in evaluating multiple primary lung adenocarcinoma.
Ma Y; Li J; Xu X; Zhang Y; Lin Y
BMC Cancer; 2022 Sep; 22(1):949. PubMed ID: 36057553
[TBL] [Abstract][Full Text] [Related]
31. CT-based radiomics and machine learning to predict spread through air space in lung adenocarcinoma.
Jiang C; Luo Y; Yuan J; You S; Chen Z; Wu M; Wang G; Gong J
Eur Radiol; 2020 Jul; 30(7):4050-4057. PubMed ID: 32112116
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans.
Khorrami M; Bera K; Thawani R; Rajiah P; Gupta A; Fu P; Linden P; Pennell N; Jacono F; Gilkeson RC; Velcheti V; Madabhushi A
Eur J Cancer; 2021 May; 148():146-158. PubMed ID: 33743483
[TBL] [Abstract][Full Text] [Related]
33. Radiomics for Classification of Lung Cancer Histological Subtypes Based on Nonenhanced Computed Tomography.
E L; Lu L; Li L; Yang H; Schwartz LH; Zhao B
Acad Radiol; 2019 Sep; 26(9):1245-1252. PubMed ID: 30502076
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of interim CT-based peritumoral and intratumoral radiomics in laryngeal and hypopharyngeal cancer patients undergoing definitive radiotherapy.
Lin CH; Yan JL; Yap WK; Kang CJ; Chang YC; Tsai TY; Chang KP; Liao CT; Hsu CL; Chou WC; Wang HM; Huang PW; Fan KH; Huang BS; Tung-Chieh Chang J; Tu SJ; Lin CY
Radiother Oncol; 2023 Dec; 189():109938. PubMed ID: 37806562
[TBL] [Abstract][Full Text] [Related]
35. Preoperative CT-based radiomics combined with tumour spread through air spaces can accurately predict early recurrence of stage I lung adenocarcinoma: a multicentre retrospective cohort study.
Wang Y; Ding Y; Liu X; Li X; Jia X; Li J; Zhang H; Song Z; Xu M; Ren J; Sun D
Cancer Imaging; 2023 Sep; 23(1):83. PubMed ID: 37679806
[TBL] [Abstract][Full Text] [Related]
36. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.
Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z
Front Oncol; 2022; 12():905551. PubMed ID: 35814460
[TBL] [Abstract][Full Text] [Related]
37. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
[TBL] [Abstract][Full Text] [Related]
38. Predicting chemotherapy response in non-small-cell lung cancer
Chang R; Qi S; Zuo Y; Yue Y; Zhang X; Guan Y; Qian W
Front Oncol; 2022; 12():915835. PubMed ID: 36003781
[TBL] [Abstract][Full Text] [Related]
39. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
40. The Machine Learning Model for Distinguishing Pathological Subtypes of Non-Small Cell Lung Cancer.
Zhao H; Su Y; Wang M; Lyu Z; Xu P; Jiao Y; Zhang L; Han W; Tian L; Fu P
Front Oncol; 2022; 12():875761. PubMed ID: 35692759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
